Allogene Therapeutics Inc (NASDAQ: ALLO) Now -55.29% Off Its High ($3.78), Does Analysts See Headwinds And Risks?
Allogene Therapeutics Inc (NASDAQ:ALLO) currently has a daily average trading volume of 5.40M but it saw 1501850 shares traded in last market. With a market cap of 367.17M USD, the company’s current market price of $1.69 came rising about 0.60 while comparing to the previous closing price of $1.68. In past 52 weeks, the stock […]
Predicting Future Price Moves In Allogene Therapeutics Inc (ALLO)
Allogene Therapeutics Inc (NASDAQ:ALLO) does about 5.30M shares in volume on a normal day but saw 1608088 shares change hands in the recent trading day. The company now has a market cap of 341.11M USD. Its current market price is $1.57, marking an increase of 1.29% compared to the previous close of $1.55. The 52 […]
Should You Sell Allogene Therapeutics Inc (ALLO) And Go Away This Year?
Allogene Therapeutics Inc (NASDAQ:ALLO) currently has a daily average trading volume of 5.39M but it saw 1578694 shares traded in last market. With a market cap of 341.11M USD, the company’s current market price of $1.57 came falling about -2.48 while comparing to the previous closing price of $1.61. In past 52 weeks, the stock […]
Allogene Therapeutics Inc (ALLO): Are Investors Missing The Big Picture?
Allogene Therapeutics Inc (NASDAQ:ALLO) does about 5.37M shares in volume on a normal day but saw 2180886 shares change hands in the recent trading day. The company now has a market cap of 308.52M USD. Its current market price is $1.42, marking a decrease of -2.07% compared to the previous close of $1.45. The 52 […]
Do Investors Have Much Faith In Allogene Therapeutics Inc (NASDAQ: ALLO)
Allogene Therapeutics Inc (NASDAQ:ALLO) does about 5.42M shares in volume on a normal day but saw 2576767 shares change hands in the recent trading day. The company now has a market cap of 310.68M USD. Its current market price is $1.43, marking a decrease of -1.38% compared to the previous close of $1.45. The 52 […]
Allogene Therapeutics Inc (NASDAQ: ALLO) Now $1.23 Higher From Its Low (0.14), Does It Still Have A Growth Story?
Allogene Therapeutics Inc (NASDAQ:ALLO) currently has a daily average trading volume of 5.49M but it saw 2572545 shares traded in last market. With a market cap of 297.66M USD, the company’s current market price of $1.37 came falling about -3.52 while comparing to the previous closing price of $1.42. In past 52 weeks, the stock […]
Allogene Therapeutics Inc (NASDAQ: ALLO) Gets A 95.73% Target Price Upside From Analysts While 10.00% Above Its 52-Week Low
Allogene Therapeutics Inc (NASDAQ:ALLO) does about 5.43M shares in volume on a normal day but saw 4857732 shares change hands in the recent trading day. The company now has a market cap of 310.69M USD. Its current market price is $1.43, marking a decrease of -0.69% compared to the previous close of $1.44. The 52 […]
Ideas And Forecasts On Allogene Therapeutics Inc (NASDAQ: ALLO)
Allogene Therapeutics Inc (NASDAQ:ALLO) currently has a daily average trading volume of 5.44M but it saw 4150542 shares traded in last market. With a market cap of 299.83M USD, the company’s current market price of $1.38 came falling about -4.17 while comparing to the previous closing price of $1.44. In past 52 weeks, the stock […]
Things For Investors To Watch In Allogene Therapeutics Inc (NASDAQ: ALLO)
Allogene Therapeutics Inc (NASDAQ:ALLO) does about 5.45M shares in volume on a normal day but saw 2904713 shares change hands in the recent trading day. The company now has a market cap of 317.21M USD. Its current market price is $1.46, marking a decrease of -5.81% compared to the previous close of $1.55. The 52 […]
Allogene Therapeutics Inc (NASDAQ: ALLO): Think Like A Lender, Not An Investor
Allogene Therapeutics Inc (NASDAQ:ALLO) currently has a daily average trading volume of 5.51M but it saw 2444394 shares traded in last market. With a market cap of 338.93M USD, the company’s current market price of $1.56 came falling about -0.64 while comparing to the previous closing price of $1.57. In past 52 weeks, the stock […]
